What Is IASTM?

What Is IASTM?

Instrument-Assisted Soft Tissue Mobilisation (IASTM) is a manual therapy technique in which specially designed metal or hard-polymer instruments are used to apply controlled mechanical force to the skin, fascial layers, tendons, ligaments, and muscles. The instruments serve as a mechanical extension of the clinician's hand — amplifying the ability to detect and treat areas of tissue dysfunction that would be difficult or inconsistent to assess by palpation alone.

The instruments are contoured with varying edge geometries: curved edges for broad surface sweeping, bevelled edges for tissue mobilisation, and pointed ends for working into smaller anatomical spaces. Different instruments serve different purposes — some optimised for the broad myofascial planes of the thoracolumbar fascia or quadriceps, others designed for precise work along the patellar tendon, the plantar fascia, or between the metatarsals.

Origins: From Gua Sha to Modern IASTM

The conceptual roots of IASTM reach back to Gua Sha — a traditional East Asian healing practice in which a smooth-edged instrument is pressed firmly against oiled skin and dragged in repeated strokes. Modern IASTM has been separated from its traditional interpretive framework and re-examined through the lens of connective tissue biology, fascial science, and mechanotransduction research. The contemporary clinical model was significantly shaped by the development of the Graston Technique in the 1990s, which brought standardised instrument designs and clinical protocols into widespread use among physiotherapists, myotherapists, and sports medicine practitioners.

How It Works

The primary mechanisms through which IASTM produces its clinical effects are mechanotransduction, inflammatory modulation, and neurophysiological pain inhibition.

Mechanotransduction refers to the process by which mechanical stimuli applied to tissue are converted into cellular biological responses. When instrument edges contact the skin and underlying fascial tissue, the mechanical forces are transmitted through the extracellular matrix to resident fibroblasts — the cells responsible for producing and remodelling collagen. Research demonstrates that this stimulation promotes fibroblast proliferation, upregulates collagen synthesis, and can shift the remodelling process from disordered type III scar collagen toward more organised, load-bearing type I collagen (Loghmani & Warden, 2009; Hammer, 2008).

In chronic tendinopathy and fascial fibrosis, the normal acute inflammatory healing response has stalled. IASTM is hypothesised to deliberately re-introduce a controlled acute inflammatory response — rebooting the healing cycle and allowing the tissue to progress through the normal phases of repair. Neurophysiological pain inhibition occurs through both spinal and supraspinal pathways via activation of skin mechanoreceptors and fascial sensory afferents, which activate inhibitory interneurons in the dorsal horn.

Clinical Indications

IASTM is indicated across a broad range of presentations, particularly those involving tendinopathy (lateral epicondylalgia, Achilles, patellar, plantar fasciopathy), post-surgical or post-traumatic scar tissue adhesions, fascial restriction of the thoracolumbar fascia, plantar fascia, IT band or cervical fasciae, chronic myofascial pain, and carpal tunnel or De Quervain's presentations where fascial thickening of retinacular structures contributes to compressive symptoms.

What the Evidence Says

A systematic review by Cheatham et al. (2016) found consistent evidence for IASTM producing improvements in pain, range of motion, and function across multiple musculoskeletal conditions. Kim et al. (2017) demonstrated measurable changes in myofascial tissue stiffness following IASTM application. Burke et al. (2020) confirmed significant effects on fascial mechanical properties. IASTM is most effective when integrated within a broader treatment programme addressing the biomechanical, neuromuscular, and loading factors perpetuating the tissue problem — it is a powerful adjunct that accelerates the window within which progressive loading and rehabilitation can take place.

What to Expect

Treatment skin is warmed and topical lubricant applied to allow the instrument to glide smoothly. The clinician works methodically through the identified region, using the instrument edge to scan for areas of increased tissue resistance — a "gritty" or "fibrotic" texture indicating fascial densification or disordered collagen architecture. Treatment strokes vary in direction, pressure, and speed depending on tissue depth and treatment phase. Post-treatment, mild petechiae (surface skin reddening) may appear — a normal, benign, temporary response indicating increased local microcirculation. Most clients experience some local tissue soreness for 24–48 hours, after which meaningful improvements in tissue mobility and pain reduction are typically reported.